Medicare Enrolled
Dr. Yan Li, M.D., PH.D.
Family Medicine · Plano, TX
Practice pattern: Clinical Cardiology— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Li from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Li? Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Li
Dr. Yan Li is a family medicine in Plano, TX, with 19 years in practice. Based on federal Medicare data, Dr. Li performed 8,246 Medicare services across 4,330 unique beneficiaries.
Between the years covered by Open Payments, Dr. Li received a total of $16,616 from 57 pharmaceutical and/or device companies across 712 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in family medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Li is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice▲ Top 2% volume in TX$ $16,616 industry payments
Medicare Practice Summary
Medicare Utilization ↗8,246
Medicare services
Top 2% in TX for family medicine
4,330
Unique beneficiaries
$35
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~434 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) | 817 | $89 | $410 |
| Office visit, established patient (20-29 min) | 701 | $63 | $355 |
| Blood draw (venipuncture) | 551 | $8 | $20 |
| Comprehensive metabolic blood panel | 521 | $10 | $65 |
| Lipid panel (cholesterol and triglycerides) | 476 | $13 | $95 |
| Complete blood count (CBC) with differential | 452 | $8 | $50 |
| Hemoglobin A1c test (diabetes monitoring) | 436 | $9 | $50 |
| Thyroid stimulating hormone (TSH) test | 431 | $16 | $90 |
| Management using the results of remote vital sign monitoring per calendar month, each additional 20 minutes | 408 | $28 | $100 |
| Steroid injection (triamcinolone) | 372 | $1 | $15 |
| Vitamin D level test | 342 | $29 | $150 |
| Vitamin B-12 level test | 310 | $15 | $80 |
| Chronic care management, first 20 min/month | 261 | $42 | $120 |
| Remote patient monitoring management, 20 min/month | 204 | $36 | $100 |
| Remote patient monitoring device, 30 days | 185 | $36 | $100 |
| Annual wellness visit, follow-up | 148 | $125 | $450 |
| Uric acid level test | 90 | $4 | $30 |
| PSA test (prostate cancer screening) | 85 | $18 | $100 |
| Measure of severe acute respiratory syndrome coronavirus 2 (covid-19) antibody | 83 | $41 | $200 |
| Drug screening test | 81 | $61 | $200 |
| Chest X-ray, 2 views | 79 | $25 | $150 |
| Automated urinalysis | 75 | $2 | $30 |
| Flu vaccine administration | 69 | $30 | $50 |
| Influenza vaccine, quadrivalent derived from cell cultures, preservative and antibiotic free | 58 | $33 | $60 |
| Office visit, established patient, complex (40-54 min) | 57 | $131 | $470 |
| Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | 55 | $35 | $200 |
| Drug injection, under skin or into muscle | 49 | $10 | $70 |
| Complete ultrasound scan of abdomen | 42 | $81 | $400 |
| Annual depression screening | 42 | $18 | $100 |
| Electrocardiogram (EKG), 12-lead | 40 | $11 | $75 |
| Injection of drug or substance into vein | 40 | $28 | $200 |
| Limited ultrasound scan behind abdominal cavity | 39 | $37 | $300 |
| Ultrasound study of arm and leg arteries | 38 | $40 | $400 |
| Office visit, established patient (10-19 min) | 37 | $40 | $250 |
| Ringers lactate infusion, up to 1000 cc | 37 | $2 | $50 |
| Hepatitis c antibody measurement | 30 | $14 | $80 |
| Carcinoembryonic antigen (cea) protein level | 28 | $19 | $100 |
| Detection test by immunoassay with direct visual observation for influenza virus | 28 | $16 | $100 |
| Joint injection, major joint | 27 | $50 | $248 |
| Detection test by immunoassay technique for hepatitis b surface antigen | 26 | $10 | $90 |
| Ultrasound of both sides of head and neck blood flow | 26 | $131 | $800 |
| Pneumonia vaccine administration | 26 | $30 | $50 |
| Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | 25 | $159 | $474 |
| Infusion into a vein for hydration, 31-60 minutes | 24 | $24 | $200 |
| Bone density scan (DEXA) | 23 | $36 | $370 |
| Immunologic analysis for detection of tumor antigen, quantitative; ca 19-9 | 23 | $20 | $130 |
| Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | 23 | $282 | $661 |
| Echocardiogram, transthoracic | 22 | $140 | $900 |
| Alpha-fetoprotein (afp) level, serum | 20 | $16 | $90 |
| Magnesium level test | 19 | $7 | $90 |
| New patient office visit (45-59 min) | 18 | $105 | $548 |
| Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3 | 17 | $20 | $120 |
| Complete ultrasound scan behind abdominal cavity | 16 | $59 | $376 |
| Colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous | 16 | $18 | $30 |
| Detection test by multiplex amplified probe technique for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (covid-19) and influenza virus types a and b | 15 | $140 | $250 |
| Ultrasound of aorta, vena cava, groin vessels or bypass grafts | 14 | $89 | $900 |
| Dxa bone density measurement of hip, pelvis, spine including spine fracture assessment | 13 | $49 | $350 |
| Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) | 12 | $16 | $40 |
| X-ray of lower and sacral spine, 2-3 views | 11 | $28 | $175 |
| Immunologic analysis for detection of tumor antigen, quantitative; ca 125 | 11 | $20 | $100 |
| Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage | 11 | $21 | $60 |
| Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | 11 | $41 | $152 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
1.2% high complexity
7.9% medium
91.0% routine
Industry Payment Transparency
Open Payments through 2024 ↗$16,616
Total received (2018-2024)
Avg $2,374/year across 7 years
Top 2% in TX for family medicine
57
Companies
712
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$14,378 (86.5%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$2,195 (13.2%)
Other
Charitable contributions, space rental, and other categories
$43 (0.3%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024$2,324
2023$2,702
2022$4,816
2021$2,272
2020$1,124
2019$1,754
2018$1,625
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Amgen Inc.
$2,419
Biohaven Pharmaceutical Holding Company Ltd.
$2,195
AstraZeneca Pharmaceuticals LP
$2,031
Gilead Sciences, Inc.
$1,460
Amarin Pharma Inc.
$1,183
Novo Nordisk Inc
$940
Lilly USA, LLC
$734
PFIZER INC.
$610
Boehringer Ingelheim Pharmaceuticals, Inc.
$592
Merck Sharp & Dohme Corporation
$569
GlaxoSmithKline, LLC.
$551
Bayer Healthcare Pharmaceuticals Inc.
$350
ABBVIE INC.
$337
Echosens North America, Inc.
$247
Biohaven Pharmaceuticals, Inc.
$232
Bayer HealthCare Pharmaceuticals Inc.
$209
Genentech USA, Inc.
$206
Merck Sharp & Dohme LLC
$160
Janssen Pharmaceuticals, Inc
$135
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$119
Foundation Medicine, Inc.
$96
RedHill Biopharma Inc.
$89
Esperion Therapeutics, Inc.
$89
ARBOR PHARMACEUTICALS, INC.
$87
AbbVie Inc.
$65
Ferring Pharmaceuticals Inc.
$63
Teva Pharmaceuticals USA, Inc.
$58
Hologic, LLC
$55
Eisai Inc.
$52
Abbott Laboratories
$52
Mannkind Corporation
$49
Shield Therapeutics Inc
$47
Optos, Inc.
$43
Exact Sciences Corporation
$39
Horizon Therapeutics plc
$37
Seqirus USA Inc
$35
Medtronic, Inc.
$28
SI-BONE, INC.
$28
Dexcom, Inc.
$27
Inspire Medical Systems, Inc.
$22
Merz North America, Inc.
$21
Nevro Corp.
$20
Astellas Pharma US Inc
$20
Takeda Pharmaceuticals U.S.A., Inc.
$19
Novartis Pharmaceuticals Corporation
$19
Eyevance Pharmaceuticals LLC
$18
Horizon Pharma plc
$18
VBI Vaccine (Delaware) Inc.
$18
Althera Pharmaceuticals LLC
$18
EISAI INC.
$16
SANOFI PASTEUR INC.
$14
MEDICOMP INC
$14
IDORSIA PHARMACEUTICALS US INC
$14
Scilex Pharmaceuticals Inc.
$13
Xeris Pharmaceuticals, Inc.
$13
Qiagen, LLC
$13
CeQur Corporation
$10
Top 3 companies account for 40.0% of total payments
Associated products mentioned in payments ›
ACCRUFER · AFREZZA · AIRSUPRA · AJOVY · AREXVY · Aimovig · Aptima · Aptima hpv · BELSOMRA · BREZTRI · BREZTRI AEROSPHERE · BYDUREON · CHANTIX · COLOGUARD DNA CAPTURE REAGENTS · COMIRNATY · CREON · CeQur Simplicity · Cologuard Collection Kit · DIFICID · DUEXIS · Dayvigo · Dexcom G6 Transmitter · ELIQUIS · EMGALITY · EUCRISA · EUFLEXXA · EVENITY · Epclusa · FARXIGA · FASENRA · FLUZONE HIGH-DOSE · FOUNDATIONONE · FREESTYLE LIBRE · FREESTYLE LIBRE 3 · FibroScan · Fluad · Fluad Quadrivalent · FreeStyle Libre 2 · GARDASIL · GARDASIL 9 · GVOKE HYPOPEN · Horizant · IFUSE IMPLANT · INSPIRE · INTELLIS ADAPTIVESTIM · JANUVIA · JARDIANCE · Kerendia · LEQVIO · LYRICA · MOUNJARO · NEXLETOL · NEXLIZET · NEXPLANON · NURTEC ODT · OFEV · Otezla · Ozempic · PANORAMIC OPHTHALMOSCOPE · PAXLOVID · PENNSAID · PREMARIN · PREVNAR 20 · PreHevbrio · Prolia · QUANTIFERON-TB GOLD PLUS · QULIPTA · QUVIVIQ · Repatha · Roszet · Rybelsus · SHINGRIX · STEGLATRO · Saxenda · Senza · TELEPATCH CARDIAC MONITOR · TRELEGY ELLIPTA · TRULICITY · TRUMENBA · Talicia · Tobradex ST · Tresiba · UBRELVY · VRAYLAR · VYVANSE · Vascepa · Vemlidy · Veozah · Victoza · Wegovy · XARELTO · XEOMIN · XIFAXAN · XIFAXANIBSD · Xofluza · ZTLido 30 POUCH in 1 CARTON 1 PATCH in 1 POUCH
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (86%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 2% for family medicine in TX.
Equivalent to $202 per 100 Medicare services performed
Geographic Context
Family Medicines within 10 mi
1,464
Per 100K population
131.1
County median income
$117,588
Nearest hospital
CHILDRENS MEDICAL CENTER PLANO
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Li is a clinical cardiology specialist, with above-average Medicare volume (top 2% in TX), and high industry engagement (low-engagement, top 2%), with 19 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Li experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Li performed 817 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Li receive payments from pharmaceutical companies?
Yes. Dr. Li received a total of $16,616 from 57 companies across 712 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Li's costs compare to other family medicines in Plano?
Dr. Li's average Medicare payment per service is $35. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Li) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Family Medicine
Common procedures, typical costs, and what industry payments mean in family medicine.
Same specialty & city
Family Medicines in Plano
Browse family medicines in Plano ranked by procedure volume and transparency data.
Highest volume
Top Family Medicines in TX
Family Medicines ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Family Medicines in TX
Which TX family medicines receive the most from drug and device companies.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc..
By company
Biohaven Pharmaceutical Holding Company Ltd. Payments to Doctors
See all physicians who received payments from Biohaven Pharmaceutical Holding Company Ltd..
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology